Subscribe Now

By entering these details you are signing up to receive our newsletter.

NHL All-Star Ryan Getzlaf returns to the links for the 12th annual Getzlaf Golf Shootout on September 9 benefiting CureDuchenne

Event has raised more than $5.3 million to find a cure for Duchenne muscular dystrophy

NEWPORT BEACH, Calif., (August 14, 2023)CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy, will partner with NHL All-Star and retired Anaheim Ducks captain Ryan Getzlaf for the 12th annual Getzlaf Golf Shootout at Monarch Beach Golf Links on September 8-9, 2023. Hosted by Ryan Getzlaf and his wife Paige, the annual Getzlaf Golf Shootout brings together professional athletes, celebrities and community leaders for an unforgettable two-day experience including an MVP Dinner reception followed by an action-packed day of activities and golf at the beautiful Monarch Beach Golf Links in Dana Point, California. 

NHL All-Star and 2007 Stanley Cup Champion Ryan Getzlaf played a remarkable 17-year career for the Anaheim Ducks, holding the record as the franchise’s all-time leading scorer and serving as team captain. Over the past 11 years, the Getzlaf family has raised more than $5.3 million at the Getzlaf Golf Shootout to fund early-stage research and bring new therapies for Duchenne muscular dystrophy. Getzlaf now serves as player development coordinator for the Ducks. 

“We are truly humbled by the generosity we receive year after year and the impact we’re able to make on the Duchenne community,” said Ryan Getzlaf. “We are closer than ever before to a cure for this devastating disease and the support of the community means more now than ever before. Together, we will find a cure.”

Duchenne muscular dystrophy, the most common and severe form of muscular dystrophy, is a fatal genetic disease affecting roughly 1 in 5,000 male births. Individuals with Duchenne are typically diagnosed as toddlers, lose the ability to walk in their early teens and often succumb to the disease in their mid-20s. Since CureDuchenne was founded in 2003, the organization has raised over $50 million for research and to develop impactful programs that help families living with Duchenne, and has funded 17 research projects that have advanced to human clinical trials.

“We are eternally grateful to the Getzlafs, our generous community, donors and athletes who support the Getzlaf Golf Shootout every year and make the fundraiser such a tremendous achievement,” said Debra Miller, founder and CEO of CureDuchenne. “Research is moving faster than ever before and we’ve made significant progress, but we must do more to ensure transformative treatments reach every individual with Duchenne. Every dollar raised and invested into cutting edge science is vital in helping us get closer to a cure.”

The golf tournament on September 9 will feature the LA Rams Cheerleaders, Ducks Power Players, games and giveaways throughout the course, including a dunk tank, hole-in-one opportunities to win a Porsche and a helicopter ball drop with a chance to win a weekend Porsche rental. Food and beverages will include a crepe station, custom beer created by Brewery X, lunch provided by Dang Brothers and In-N-Out Burger and on-course smoked barbeque by Bad to the Bone BBQ. 

For more information about the Getzlaf Golf Shootout, please visit getzlafgolf.org

About CureDuchenne 
Twenty years ago, CureDuchenne was created with one goal: to find and fund a cure for Duchenne muscular dystrophy, the leading genetic killer of young boys. Today, CureDuchenne is recognized as a global leader in research, patient care, and innovation for improving and extending the lives of those with Duchenne. CureDuchenne’s innovative venture philanthropy model has advanced transformative treatments for Duchenne muscular dystrophy, including 17 projects that advanced to human clinical trials and multiple projects to overcome the limitations of exon-skipping and gene therapy. In addition, CureDuchenne contributed early funding to the first FDA-approved Duchenne drug, pioneered the first and only Duchenne physical and occupational therapist certification program and created an innovative biobank and data registry, accelerating research toward a cure. For more information on how to help raise awareness and funds needed for research, please visit cureduchenne.org.


Skip to content